{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:51:31Z","timestamp":1791233491277,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"The drug quality programme was funded by the Bill & Melinda Gates Foundation as part of an award to the artemisinin combination therapy consortium at the London School of Hygiene & Tropical Medicine."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12936-016-1096-x","type":"journal-article","created":{"date-parts":[[2016,2,13]],"date-time":"2016-02-13T06:25:54Z","timestamp":1455344754000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Fake anti-malarials: start with the facts"],"prefix":"10.1186","volume":"15","author":[{"given":"Harparkash","family":"Kaur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si\u0203n","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirza","family":"Lalani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souly","family":"Phanouvong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Gu\u00e9rin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"McLoughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin K.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Deats","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Plan\u00e7on","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debora","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Schellenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,13]]},"reference":[{"key":"1096_CR1","volume-title":"World Malaria Report 2014","author":"WHO","year":"2014","unstructured":"WHO. World Malaria Report 2014. Geneva: World Health Organization; 2014."},{"key":"1096_CR2","unstructured":"Review on antimicrobial resistance. Available at Tackling drug-resistance infections globally: http:\/\/amrreview.org\/sites\/default\/files\/Safe%2C%20secure%20and%20controlled%20%0Managing%20the%20supply%20chai%20of%20antimicrobials.pdf ."},{"key":"1096_CR3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11096-004-0558-3","volume":"26","author":"L Syhakhang","year":"2004","unstructured":"Syhakhang L, Lundborg CS, Lindgren B, Tomson G. The quality of drugs in private pharmacies in Lao PDR: a repeat study in 1997 and 1999. Pharm World Sci. 2004;26:333\u20138.","journal-title":"Pharm World Sci"},{"key":"1096_CR4","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0277-9536(00)00142-8","volume":"52","author":"B Stenson","year":"2001","unstructured":"Stenson B, Syhakhang L, Eriksson B. Real world pharmacy: assessing the quality of private pharmacy practice in the Lao People\u2019s Democratic Republic. Soc Sci Med. 2001;52:393\u2013404.","journal-title":"Soc Sci Med"},{"key":"1096_CR5","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3233\/JRS-1998-161","volume":"11","author":"B Stenson","year":"1998","unstructured":"Stenson B, Lindgren BH, Syhakhang L, Tomson G. The quality of drugs in private pharmacies in the Lao People\u2019s Democratic Republic. Int J Risk Saf Med. 1998;11:243\u20139.","journal-title":"Int J Risk Saf Med"},{"key":"1096_CR6","unstructured":"United States Pharmacopeial Convention, 2004. A review of drug quality in Asia with focus on anti-infectives. Drug quality and information program. http:\/\/pdf.usaid.gov\/pdf_docs\/PNADH154.pdf ."},{"key":"1096_CR7","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/S0140-6736(00)05085-6","volume":"357","author":"P Newton","year":"2001","unstructured":"Newton P, Proux S, Green M, Smithuis F, Rozendaal J, Prakongpan S, et al. Fake artesunate in Southeast Asia. Lancet. 2001;357:1948\u201350.","journal-title":"Lancet"},{"key":"1096_CR8","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/pgmj.2008.073213","volume":"85","author":"CS Gautam","year":"2009","unstructured":"Gautam CS, Utreja A, Singal GL. Spurious and counterfeit drugs: a growing industry in the developing world. Postgrad Med J. 2009;85:251\u20136.","journal-title":"Postgrad Med J"},{"key":"1096_CR9","doi-asserted-by":"crossref","first-page":"e7381","DOI":"10.1136\/bmj.e7381","volume":"345","author":"A Attaran","year":"2012","unstructured":"Attaran A, Barry D, Basheer S, Bate R, Benton D, Chauvin J. How to achieve international action on falsified and substandard medicines. BMJ. 2012;345:e7381.","journal-title":"BMJ"},{"key":"1096_CR10","unstructured":"WHO \u2018Counterfeits: Frequently Asked Questions\u2019. http:\/\/www.who.int\/medicines\/services\/counterfeit\/faqs\/QandAsUpdateJuly11.pdf ."},{"key":"1096_CR11","unstructured":"Analysing the quality and authenticity of ACT drugs. http:\/\/www.actconsortium.org\/projects\/9\/analysing-the-quality-and-authenticity-of-act-drugs ."},{"key":"1096_CR12","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S1473-3099(12)70064-6","volume":"12","author":"GM Nayyar","year":"2012","unstructured":"Nayyar GM, Breman JG, Newton PN, Herrington J. Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa. Lancet Infect Dis. 2012;12:488\u201396.","journal-title":"Lancet Infect Dis"},{"key":"1096_CR13","unstructured":"Report on the meeting one the survey of the quality of antimalarials in subsaharan Africa (QAMSA). In: Survey of the quality of antimalarials in subsaharan Africa; 6\u20138 July 2010; Silver Springs Hotel, Nairobi, Kenya, World Health Organisation; 2010."},{"key":"1096_CR14","unstructured":"Survey of the quality of selected antimalarial medicines circulating in six countries of sub-Saharan Africa. http:\/\/www.who.int\/medicines\/publications\/WHO_QAMSA_report.pdf ."},{"key":"1096_CR15","unstructured":"Drug quality. http:\/\/www.wwarn.org\/about-us\/drug-quality ."},{"key":"1096_CR16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/1475-2875-13-139","volume":"13","author":"P Tabernero","year":"2014","unstructured":"Tabernero P, Fernandez FM, Green M, Guerin PJ, Newton PN. Mind the gaps\u2013the epidemiology of poor-quality anti-malarials in the malarious world\u2013analysis of the WorldWide Antimalarial Resistance Network database. Malar J. 2014;13:139.","journal-title":"Malar J"},{"key":"1096_CR17","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1371\/journal.pmed.1000052","volume":"6","author":"PN Newton","year":"2009","unstructured":"Newton PN, Lee SJ, Goodman C, Fernandez FM, Yeung S, Phanouvong S, et al. Guidelines for field surveys of the quality of medicines: a proposal. PLoS Med. 2009;6:e52.","journal-title":"PLoS Med"},{"key":"1096_CR18","doi-asserted-by":"crossref","first-page":"e0125577","DOI":"10.1371\/journal.pone.0125577","volume":"10","author":"H Kaur","year":"2015","unstructured":"Kaur H, Allan EL, Mamadu I, Hall Z, Ibe O, El Sherbiny M, et al. Quality of artemisinin-based combination formulations for malaria treatment: prevalence and risk factors for poor quality medicines in public facilities and private sector drug outlets in Enugu, Nigeria. PLoS ONE. 2015;10:e0125577.","journal-title":"PLoS ONE"},{"key":"1096_CR19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4269\/ajtmh.14-0391","volume":"92","author":"S Yeung","year":"2015","unstructured":"Yeung S, Lawford HL, Tabernero P, Nguon C, van Wyk A, Malik N, et al. Quality of antimalarials at the epicenter of antimalarial drug resistance: results from an overt and mystery client survey in Cambodia. Am J Trop Med Hyg. 2015;92:39\u201350.","journal-title":"Am J Trop Med Hyg"},{"key":"1096_CR20","unstructured":"Marketing oral artemisinin monotherapies at country level. http:\/\/www.who.int\/entity\/malaria\/monotherapy_NDRAs.pdf?ua=1 ."},{"key":"1096_CR21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00216-010-3748-y","volume":"398","author":"R Martino","year":"2010","unstructured":"Martino R, Malet-Martino M, Gilard V, Balayssac S. Counterfeit drugs: analytical techniques for their identification. Anal Bioanal Chem. 2010;398:77\u201392.","journal-title":"Anal Bioanal Chem"},{"key":"1096_CR22","unstructured":"Spinning into focus. http:\/\/www.rsc.org\/chemistryworld\/2014\/01\/nmr-product-guide ."},{"key":"1096_CR23","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.aca.2008.06.007","volume":"623","author":"C Ricci","year":"2008","unstructured":"Ricci C, Nyadong L, Yang F, Fernandez FM, Brown CD, Newton PN, et al. Assessment of hand-held Raman instrumentation for in situ screening for potentially counterfeit artesunate antimalarial tablets by FT-Raman spectroscopy and direct ionization mass spectrometry. Anal Chim Acta. 2008;623:178\u201386.","journal-title":"Anal Chim Acta"},{"key":"1096_CR24","unstructured":"A comparison of four commercially available portable Raman spectrometers. www.nfstc.org\/?dlid=214 ."},{"key":"1096_CR25","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2217\/thy.09.84","volume":"7","author":"H Kaur","year":"2010","unstructured":"Kaur H, Green MD, Hostetler D, Fernandez FM, Newton PN. Antimalarial drug quality: methods to detect suspect drugs. Therapy. 2010;7:40\u201357.","journal-title":"Therapy"},{"key":"1096_CR26","unstructured":"Guidelines for drug sampling. http:\/\/www.usp.org\/sites\/default\/files\/usp_pdf\/EN\/dqi\/samplingGuidelines.pdf ."},{"issue":"suppl 6","key":"1096_CR27","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4269\/ajtmh.14-0544","volume":"92","author":"ACTCDQ Project and IMPACT2 Study Team","year":"2015","unstructured":"ACTCDQ Project and IMPACT2 Study Team. Quality of artemisinin-containing antimalarials in Tanzania\u2019s private sector-results from a nationally representative outlet survey. Am J Trop Med Hyg. 2015;92(suppl 6):75\u201386.","journal-title":"Am J Trop Med Hyg"},{"key":"1096_CR28","doi-asserted-by":"crossref","unstructured":"Hall Z, Allan E, van Schalkwyk D, van Wyk, A, Kaur H. Degradation of artemisinin-based combination therapies under tropical conditions. Am J Trop Med Hyg. 2016 (accepted).","DOI":"10.4269\/ajtmh.15-0665"},{"key":"1096_CR29","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nrmicro2385","volume":"8","author":"AM Dondorp","year":"2010","unstructured":"Dondorp AM, Yeung S, White L, Nguon C, Day NP, Socheat D, et al. Artemisinin resistance: current status and scenarios for containment. Nat Rev Microbiol. 2010;8:272\u201380.","journal-title":"Nat Rev Microbiol"},{"key":"1096_CR30","unstructured":"France T: Widespread artemisinin resistance could wipe out a decade of malaria investment. World Malaria Day; 2015. http:\/\/www.worldmalariaday.org\/archives\/13447 ."},{"key":"1096_CR31","unstructured":"PQM: promoting the quality of medicines in developing countries. http:\/\/www.usp.org\/global-health-impact-programs\/promoting-quality-medicines-pqmusaid ."},{"key":"1096_CR32","unstructured":"WHO surveillance and rapid alert system for substandard\/spurious\/falsely labelled\/falsified\/counterfeit (SSFFC) medical products. http:\/\/www.euro.who.int\/en\/health-topics\/Healthsystems\/medicines\/news\/news\/2014\/06\/who-surveillance-and-rapid-alert-system-for-substandardspuriousfalselylabelledfalsifiedcounterfeit-ssffc-medical-products ."},{"key":"1096_CR33","unstructured":"GPHF minilab. www.gphf.org ."}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-016-1096-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T11:05:21Z","timestamp":1748775921000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.malariajournal.com\/content\/15\/1\/86"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,13]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1096"],"URL":"https:\/\/doi.org\/10.1186\/s12936-016-1096-x","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,13]]},"article-number":"86"}}